glp 1 providers near me Ozempic Weight Loss Injections in Frederick MD Medically Guided Weight Loss Membership
Description
and is not a GLP-1 agonist drug.**
The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031
Best For: Clients beginning their weight loss journey
Eli Lillys first nine months of 2025 underscored the scale of the GLP-1 surge: Mounjaro and Zepbound generated $39.5 billion in revenue and surpasses Mercks Keytruda as the worlds best-selling medicine[5]
A recent article by Paggers et al
